USPTO 2015–2025 USPTO PatentsView US Corporation

Crossroads Extremity Systems, LLC

USPTO PatentsView assignee record - 68 granted patents across 5 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Crossroads ranks #5,067 of 49,997 tracked US assignees by granted-patent volume, with 68 patents across 5 technology areas.

#5,067
of 49,997 US assignees by volume
Top 38%
by Innovation Score (39.5/100)
15.9
avg claims per patent
+478%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5067 · US Corporation #5,067 · 68 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 68 grants
  • UPPER-Q #5,067/49,997
  • PHOTO-FINISH Calix
  • CPC-NARROW A61B · 5 areas
  • INNOV-THIN 39.5/100
  • CLAIMS-RICH 15.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +478% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Calix, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Crossroads’s 39.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Crossroads

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Crossroads's Innovation Score is 39.5/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Crossroads?

Each dot is one of Crossroads’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Crossroads’s own 15.9 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Crossroads vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 67.968.068.06868.068.068.1 510152025 Granted patents (volume) Avg claims / patent Chiyoda Corporation - 68, 8.04ChiyodaCalix, Inc. - 68, 19.82CalixCareFusion Germany 326 GmbH - 68, 17.96Carefusion German…China University of Mining and Technology-Beijing - 68, 10.38China University…Daimler Truck AG - 68, 6.69Daimler TruckElectro Scientific Industries, Inc. - 68, 20.38Electro Scientifi…ExtraHop Networks, Inc. - 68, 23.88Extrahop NetworksF. Hoffmann-La Roche AG - 68, 12.46F Hoffmann-la Roc…Crossroads Extremity Systems, LLC - 68, 15.91Crossroads Extrem…
Crossroads vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Crossroads's grants concentrate

Crossroads Extremity Systems, LLC is a focused PatentsView assignee: 5 CPC subclasses with 89.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (14 grants) versus a trough of 2 in 2018. By volume, Crossroads sits between Chiyoda Corporation and F. Hoffmann-La Roche AG.

Crossroads's three-year grant acceleration

From 2019–2021 to 2022–2024, Crossroads Extremity Systems, LLC moved from 28 to 31 grants (1.11x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Crossroads's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Crossroads holds 68 patents at rank #5,067, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Crossroads

By rank, the assignees closest to #5,067 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Crossroads's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Crossroads, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Crossroads ranks #302 of 7,127 assignees by patent count in that subclass.

Crossroads's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20182019202020212022202320242025 7
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Crossroads Extremity Systems, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 2.9%
2019 7 10.3%
2020 10 14.7%
2021 11 16.2%
2022 13 19.1%
2023 4 5.9%
2024 14 20.6%
2025partial year 7 10.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Crossroads Extremity Systems, LLC's patent record in context - here's where to go next.

  • Crossroads Extremity Systems, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 89.7% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #5,067 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Crossroads Extremity Systems, LLC against Chiyoda Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.